According to analysis of a number of clinical trials by research teams at the University of Sydney and the University of Oxford, statin drugs could reduce stroke and heart risks amongst diabetics, and should play a greater role in diabetes treatment throughout the world.
The research teams conducted the most in-depth review to date, and found that statins did provide health benefits to diabetics with metabolic disorders affecting the regulation of blood sugar .
The study, published in medical journal The Lancet, could persuade doctors to prescribe statins to diabetics. The heart drugs, popular in the 1980s, included Lipitor (Pfizer) and Crestor (AstraZeneca).
A co-author of the report, Professor Colin Baigent, reportedly commented: “People with diabetes are at a substantially higher risk of cardiovascular disease . Young or old, woman or ma, overweight or not, all people we studied would benefit from a statin.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…